Ercc2Mhdarco15/Ercc2+
C3HeB/FeJ-Ercc2Mhdarco15
|
abnormal response to radiation |
J:223515
|
Ercc2Mhdarco15/Ercc2Mhdarco15
C3HeB/FeJ-Ercc2Mhdarco15
|
abnormal lens morphology |
J:223515
|
decreased body size |
J:223515
|
developmental cataract |
J:223515
|
female infertility |
J:223515
|
lens vacuoles |
J:223515
|
microphthalmia |
J:223515
|
nuclear cataract |
J:223515
|
normal
reproductive system phenotype |
J:223515
|
rough coat |
J:223515
|
small lens |
J:223515
|
Ercc2tm1Jhjh/Ercc2tm1Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
embryonic lethality before implantation, complete penetrance |
J:45017
|
Ercc2tm1Jhjh/Ercc2tm2(ERCC2)Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
abnormal hair cuticle |
J:48256
|
abnormal hair follicle morphology |
J:48256
|
abnormal hemoglobin |
J:48256
|
acanthosis |
J:48256
|
alopecia |
J:48256
|
anemia |
J:48256
|
brittle hair |
J:48256
|
cachexia |
J:48256
|
decreased erythrocyte cell number |
J:48256
|
decreased hematocrit |
J:48256
|
decreased total body fat amount |
J:48256
|
greasy coat |
J:48256
|
hyperkeratosis |
J:48256
|
increased cellular sensitivity to ultraviolet irradiation |
J:116054
|
increased incidence of tumors by chemical induction |
J:48256
|
increased incidence of tumors by UV-induction |
J:48256
|
increased skin tumor incidence |
J:48256
|
postnatal growth retardation |
J:48256
|
premature death |
J:48256
|
scaly skin |
J:48256
|
thick skin |
J:48256
|
tremors |
J:48256
|
Ercc2tm1Jmch/Ercc2tm1Jmch
involves: 129P2/OlaHsd * C57BL/6
|
embryonic lethality before implantation, complete penetrance |
J:116054
|
Ercc2tm1Jmch/Ercc2tm2(ERCC2)Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
decreased cellular sensitivity to ultraviolet irradiation |
J:116054
|
focal dorsal hair loss |
J:116054
|
normal
growth/size/body region phenotype |
J:116054
|
normal
mortality/aging |
J:116054
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
involves: 129P2/OlaHsd
|
normal
immune system phenotype |
J:47993
|
increased cellular sensitivity to ultraviolet irradiation |
J:145759
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
abnormal cell physiology |
J:112689
|
abnormal circulating amino acid level |
J:76608
|
abnormal coat/ hair morphology |
J:48256
|
abnormal epidermis stratum granulosum morphology |
J:116054
|
abnormal fat cell morphology |
J:48256
|
abnormal hair follicle morphology |
J:48256
|
abnormal ovulation |
J:76608
|
abnormal sebaceous gland morphology |
J:116054
|
abnormal skeleton morphology |
J:48256
|
acanthosis |
J:48256,
J:116054
|
alopecia |
J:48256
|
anemia |
J:76608,
J:116054
|
brittle hair |
J:48256,
J:116054
|
cachexia |
J:48256,
J:76608,
J:116054
|
decreased bone mineral density |
J:76608
|
decreased erythrocyte cell number |
J:76608
|
decreased hematocrit |
J:76608
|
decreased hemoglobin content |
J:76608
|
disproportionate dwarf |
J:48256
|
enlarged hair follicles |
J:48256
|
enlarged sebaceous gland |
J:76608
|
enlarged spleen |
J:76608
|
greasy coat |
J:48256,
J:116054
|
hyperkeratosis |
J:48256,
J:116054
|
increased incidence of induced tumors |
J:48256
|
kyphosis |
J:76608,
J:116054
|
normal
neoplasm |
J:112689
|
osteoporosis |
J:76608,
J:116054
|
postnatal growth retardation |
J:48256,
J:116054
|
premature aging |
J:76608
|
premature death |
J:48256,
J:116054
|
reduced female fertility |
J:48256,
J:76608
|
scaly skin |
J:48256
|
sparse hair |
J:116054
|
thick skin |
J:48256
|
tremors |
J:48256
|
white spotting |
J:76608
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2Jmch
involves: 129P2/OlaHsd * C57BL/6
|
anemia |
J:116054
|
brittle hair |
J:116054
|
decreased cellular sensitivity to ultraviolet irradiation |
J:116054
|
focal dorsal hair loss |
J:116054
|
normal
growth/size/body region phenotype |
J:116054
|
normal
integument phenotype |
J:116054
|
normal
mortality/aging |
J:116054
|
postnatal growth retardation |
J:116054
|
normal
skeleton phenotype |
J:116054
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm3Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
normal
integument phenotype |
J:116054
|
Ercc2tm2Jmch/Ercc2tm2Jmch
involves: 129P2/OlaHsd * C57BL/6
|
embryonic lethality before implantation, complete penetrance |
J:116054
|
Ercc2tm3Jhjh/Ercc2tm3Jhjh
involves: 129 * C57BL/6J
|
astrocytosis |
J:179808
|
microgliosis |
J:179808
|
Ercc2tm3Jhjh/Ercc2tm3Jhjh
involves: 129P2/OlaHsd * C57BL/6
|
increased cellular sensitivity to ultraviolet irradiation |
J:116054
|
Ercc2tm3Jhjh/Ercc2tm3Jhjh
involves: 129P2/OlaHsd * C57BL/6 * FVB
|
abnormal DNA repair |
J:112689
|
abnormal testis morphology |
J:112689
|
acanthosis |
J:112689
|
cachexia |
J:112689
|
corneal opacity |
J:112689
|
decreased exploration in new environment |
J:112689
|
decreased tumor latency |
J:112689
|
normal
hematopoietic system phenotype |
J:112689
|
increased cellular sensitivity to ultraviolet irradiation |
J:112689
|
increased incidence of tumors by UV-induction |
J:112689
|
normal
integument phenotype |
J:112689
|
limb grasping |
J:112689
|
normal
nervous system phenotype |
J:112689
|
postnatal growth retardation |
J:112689
|
premature death |
J:112689
|
reddish skin |
J:112689
|
normal
reproductive system phenotype |
J:112689
|
skin photosensitivity |
J:112689
|